drugset / Trial / NCT00461344
Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Primary: To determine the pathological remission following the chemotherapy combination docetaxel and doxorubicin in large breast cancer Secondary: * Clinical response rate * To investigate the safety of docetaxel doxorubicin combination in the treatment for neoadjuvant chemotherapy of breast cancer * Type of surgery (radical/conservative)
Timeline
- Start
- 2004-07
- Primary completion
- 2005-06
- Completion
- 2007-08
Outcome
Outcome not reported
Stopped (Enrollment): “due to slow recruitment of patients”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |